blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1720546

EP1720546 - NOVEL, SUSTAINED-ACTION BETA-2-AGONISTS AND THEIR USE AS MEDICAMENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.07.2011
Database last updated on 15.06.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  MC  NL  PL  PT  RO  SE  SI  SK  TR 
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
For:DE 
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2006/46]For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  MC  NL  PL  PT  RO  SE  SI  SK  TR 
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
For:DE 
Boehringer Ingelheim Pharma GmbH & Co.KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Inventor(s)01 / BOUYSSOU, Thierry
Berggrubenweg Nr. 21
88447 Birkenhard / DE
02 / HOENKE, Christoph
Turnierstrasse 43
55218 Ingelheim / DE
03 / KONETZKI, Ingo
Müllerweg 9
88447 Warthausen / DE
04 / MACK, Jürgen
Maria-Menz-Weg 12
88400 Biberach / DE
05 / SCHNAPP, Andreas
Esterbuch 5
88400 Biberach / DE
 [2007/04]
Former [2006/46]01 / BOUYSSOU, Thierry
Berggrubenweg Nr. 21
88447 Birkenhard / DE
02 / HOENKE, Christoph
Turnierstrasse 43
55218 Ingelheim / DE
03 / KONETZKI, Ingo
Müllerweg 9
88447 Warthausen / DE
04 / MACK, Jürgen
Amriswilstrasse 7
88400 Biberach / DE
05 / SCHNAPP, Andreas
Esterbuch 5
88400 Biberach / DE
Representative(s)Hammann, Heinz
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2006/46]Hammann, Heinz
Boehringer Ingelheim Pharma GmbH & Co. KG Binger Strasse 173
55216 Ingelheim am Rhein / DE
Application number, filing date05707250.608.02.2005
[2006/46]
WO2005EP01232
Priority number, dateEP2004000335414.02.2004         Original published format: EP 04003354
[2006/46]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2005077361
Date:25.08.2005
Language:DE
[2005/34]
Type: A1 Application with search report 
No.:EP1720546
Date:15.11.2006
Language:DE
The application published by WIPO in one of the EPO official languages on 25.08.2005 takes the place of the publication of the European patent application.
[2006/46]
Type: B1 Patent specification 
No.:EP1720546
Date:01.09.2010
Language:DE
[2010/35]
Search report(s)International search report - published on:EP25.08.2005
ClassificationIPC:A61K31/4196, A61P11/06, C07D249/08, C07D405/04
[2006/46]
CPC:
C07D249/08 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P31/00 (EP); A61P33/00 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P43/00 (EP); C07D405/04 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/46]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:NEUE LANGWIRKSAME BETA-2-AGONISTEN, UND DEREN VERWENDUNG ALS ARZNEIMITTEL[2006/46]
English:NOVEL, SUSTAINED-ACTION BETA-2-AGONISTS AND THEIR USE AS MEDICAMENTS[2006/46]
French:NOUVEAUX BETA-2-AGONISTES A ACTION LONGUE DUREE ET LEUR UTILISATION COMME MEDICAMENTS[2006/46]
Entry into regional phase14.09.2006National basic fee paid 
14.09.2006Designation fee(s) paid 
14.09.2006Examination fee paid 
Examination procedure14.09.2006Examination requested  [2006/46]
08.08.2007Despatch of a communication from the examining division (Time limit: M06)
14.02.2008Reply to a communication from the examining division
16.12.2008Despatch of a communication from the examining division (Time limit: M04)
23.03.2009Reply to a communication from the examining division
06.04.2010Communication of intention to grant the patent
22.07.2010Fee for grant paid
22.07.2010Fee for publishing/printing paid
Opposition(s)06.06.2011No opposition filed within time limit [2011/32]
Fees paidRenewal fee
28.02.2007Renewal fee patent year 03
29.02.2008Renewal fee patent year 04
02.03.2009Renewal fee patent year 05
01.03.2010Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY01.09.2010
CZ01.09.2010
DK01.09.2010
EE01.09.2010
FI01.09.2010
HU01.09.2010
IE01.09.2010
LT01.09.2010
NL01.09.2010
PL01.09.2010
RO01.09.2010
SE01.09.2010
SI01.09.2010
SK01.09.2010
TR01.09.2010
BG01.12.2010
GR02.12.2010
IS01.01.2011
PT03.01.2011
LU08.02.2011
BE28.02.2011
MC28.02.2011
[2013/45]
Former [2013/44]CY01.09.2010
CZ01.09.2010
DK01.09.2010
EE01.09.2010
FI01.09.2010
IE01.09.2010
LT01.09.2010
NL01.09.2010
PL01.09.2010
RO01.09.2010
SE01.09.2010
SI01.09.2010
SK01.09.2010
TR01.09.2010
BG01.12.2010
GR02.12.2010
IS01.01.2011
PT03.01.2011
LU08.02.2011
BE28.02.2011
MC28.02.2011
Former [2013/42]CY01.09.2010
CZ01.09.2010
DK01.09.2010
EE01.09.2010
FI01.09.2010
IE01.09.2010
LT01.09.2010
NL01.09.2010
PL01.09.2010
RO01.09.2010
SE01.09.2010
SI01.09.2010
SK01.09.2010
BG01.12.2010
GR02.12.2010
IS01.01.2011
PT03.01.2011
LU08.02.2011
BE28.02.2011
MC28.02.2011
Former [2013/25]CY01.09.2010
CZ01.09.2010
DK01.09.2010
EE01.09.2010
FI01.09.2010
IE01.09.2010
LT01.09.2010
NL01.09.2010
PL01.09.2010
RO01.09.2010
SE01.09.2010
SI01.09.2010
SK01.09.2010
GR02.12.2010
IS01.01.2011
PT03.01.2011
LU08.02.2011
BE28.02.2011
MC28.02.2011
Former [2012/01]CY01.09.2010
CZ01.09.2010
DK01.09.2010
EE01.09.2010
FI01.09.2010
IE01.09.2010
LT01.09.2010
NL01.09.2010
PL01.09.2010
RO01.09.2010
SE01.09.2010
SI01.09.2010
SK01.09.2010
GR02.12.2010
IS01.01.2011
PT03.01.2011
BE28.02.2011
MC28.02.2011
Former [2011/45]CY01.09.2010
CZ01.09.2010
DK01.09.2010
EE01.09.2010
FI01.09.2010
IE01.09.2010
LT01.09.2010
NL01.09.2010
PL01.09.2010
RO01.09.2010
SE01.09.2010
SI01.09.2010
SK01.09.2010
GR02.12.2010
IS01.01.2011
PT03.01.2011
MC28.02.2011
Former [2011/40]CY01.09.2010
CZ01.09.2010
DK01.09.2010
EE01.09.2010
FI01.09.2010
IE01.09.2010
LT01.09.2010
NL01.09.2010
PL01.09.2010
RO01.09.2010
SE01.09.2010
SI01.09.2010
SK01.09.2010
GR02.12.2010
IS01.01.2011
PT03.01.2011
Former [2011/29]CY01.09.2010
CZ01.09.2010
EE01.09.2010
FI01.09.2010
IE01.09.2010
LT01.09.2010
NL01.09.2010
PL01.09.2010
RO01.09.2010
SE01.09.2010
SI01.09.2010
SK01.09.2010
GR02.12.2010
IS01.01.2011
PT03.01.2011
Former [2011/23]CY01.09.2010
CZ01.09.2010
EE01.09.2010
FI01.09.2010
IE01.09.2010
LT01.09.2010
NL01.09.2010
PL01.09.2010
SE01.09.2010
SI01.09.2010
SK01.09.2010
GR02.12.2010
IS01.01.2011
Former [2011/19]CY01.09.2010
FI01.09.2010
IE01.09.2010
LT01.09.2010
NL01.09.2010
PL01.09.2010
SE01.09.2010
SI01.09.2010
GR02.12.2010
Former [2011/17]CY01.09.2010
FI01.09.2010
LT01.09.2010
NL01.09.2010
PL01.09.2010
SE01.09.2010
SI01.09.2010
GR02.12.2010
Former [2011/15]CY01.09.2010
FI01.09.2010
LT01.09.2010
PL01.09.2010
SE01.09.2010
SI01.09.2010
GR02.12.2010
Former [2011/13]CY01.09.2010
FI01.09.2010
LT01.09.2010
PL01.09.2010
SI01.09.2010
Former [2011/11]FI01.09.2010
LT01.09.2010
PL01.09.2010
SI01.09.2010
Former [2011/08]LT01.09.2010
Cited inInternational search[DY]EP0008653  (BOEHRINGER SOHN INGELHEIM [DE]) [DY] 1-17 * Seite 27 dritte Verbindung; * * claim - *;
 [DY]WO0183462  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [DY] 1-17 * claim - ** page 9; example 5 *;
 [PX]WO2004039784  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [PX] 7-13,15 * claims 4,9 * * page 12, line 16 - line 17 * * page 15, lines 1-3 * * page 15, line 21 - line 26 * * table 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.